Skip to Main Content

Paper Details

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
Sci Immunol
452
2020
COVID-19, HKU1, IgA, IgG, IgG antibodies, IgM, IgM antibodies, NL63, OC43, RBD, SARS-CoV, SARS-CoV-2, SARS-CoV-2 RBD, SARS-CoV-2 spike protein, anti-RBD IgG, anti-S neutralizing antibody, blood, human, patients, spike (S) protein
Author NameAffiliation
Wilfredo F Garcia-BeltranMassachusetts General Hospital
Stephanie FischingerRagon Institute of MGH
Anthony J IafrateMassachusetts General Hospital
Dan H BarouchRagon Institute of MGH
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Galit AlterRagon Institute of MGH
Edward T RyanMassachusetts General Hospital
Edward T RyanHarvard Medical School
Edward T RyanHarvard T.H. Chan School of Public Health
Richelle C CharlesMassachusetts General Hospital
Richelle C CharlesHarvard Medical School
  • 1 - 11

Datasets

Release 1.2